Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for preventing and treating cardiovascnlar and cerebrovascular diseases

A technology for cardiovascular and cerebrovascular diseases and compositions, applied in the field of pharmaceutical preparations, can solve the problems of unsatisfactory cardiovascular and cerebrovascular diseases, slow onset of active ingredients, low bioavailability, etc., to enhance the immune function of the body and reduce myocardial oxygen consumption Quantity, good therapeutic effect

Inactive Publication Date: 2016-04-06
曹永芬
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional western medicines include nitrate lipids, β-receptor blockers, calcium antagonists, etc. Although they work quickly, they all have certain toxic and side effects, so they should not be taken for a long time
The active ingredients of traditional Chinese medicine preparations have a slow onset of action and low bioavailability; in recent years, preparations with good market response, such as Compound Danshen Dripping Pills, Suxiao Jiuxin Pills, and Naofukang Tablets, have achieved positive clinical application effects. However, its indications are relatively single, and it cannot meet the clinical needs of various cardiovascular and cerebrovascular diseases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Example 1: The pharmaceutical composition of the present invention is prepared from the following raw materials by weight: 0.2-1.0 part of eicosatetraenoic acid (ARA) powder, 0.1-0.5 part of docosahexaenoic acid (DHA) microcapsule powder , 50 to 60 parts of Pueraria, 20 to 35 parts of Tinglizi, 3 to 9 parts of leeches, and 3 to 9 parts of Panax notoginseng. The preparation method is as follows: mixing the above-mentioned pueraria, tincture, leeches, and Panax notoginseng in parts by weight, and then sending them into a dryer for drying, and constantly turning them during drying to prevent sticking to the pot. 10-12%, stop heating, take out and cool, when the temperature drops to room temperature, send it to an ultrafine pulverizer for pulverization, and stop when it passes through a 106-micron sieve, and then ripen and sterilize the material under the sieve. The temperature is 105~110℃, the time is 30~35min, and it is ready for use; Weigh parts by weight of eicosatetra...

Embodiment 2

[0008] Example 2: The pharmaceutical composition of the present invention is preferably prepared from raw materials in parts by weight: 1 part of eicosatetraenoic acid (ARA) powder, 1 part of docosahexaenoic acid (DHA) microcapsule powder, 50 parts of pueraria , 30 parts of Tinglizi, 9 parts of leeches, 9 parts of Panax notoginseng; its preparation method and administration method are the same as those of embodiment 1.

[0009] Medical case example:

[0010] Case 1: Mr. Lu, male, 58 years old, retired worker, from Jilin City, Jilin Province, the patient complained: palpitation after exertion, dyspnea, hypertension and hyperlipidemia for more than 10 years, the electrocardiogram showed myocardial ischemia, coronary angiography Shows sclerosis, according to clinical symptom diagnosis shows that the patient suffers from coronary heart disease, myocardial ischemia, after taking the medicine of the present invention for 30 days, blood pressure, blood lipids are stable, palpitat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for preventing and treating cardiovascnlar and cerebrovascular diseases. The medicine composition is prepared from, by weight, 0.2-1.0 part of eicosatetraenoic acid powder, 0.1-0.5 part of docosahexenoic acid micro-capsule powder, 50-60 parts of lobed kudzuvine roots, 20-35 parts of Lepidium apetalum Willd., 3-9 parts of leeches and 3-9 parts of pseudo-ginseng. A preparation method of the medicine composition includes the steps of mixing, by weight, lobed kudzuvine roots, Lepidium apetalum Willd., leeches and pseudo-ginseng together, sending the mixture into a dryer to be dried, stopping heating when the moisture of the mixture reaches 10%, taking out the mixture to be cooled, sending the mixture into an ultrafine grinder to be ground after the temperature is lowered to the room temperature, conducting curing and sterilizing when the mixture passes through a 106-micrometer screen for standby application, weighing, by weight, eicosatetraenoic acid powder and docosahexenoic acid micro-capsule powder to be put into a stirring machine together with the material for standby application to be mixed, conducting tabletting according to a conventional pharmaceutical preparation technology or filling the mixture into capsules after the materials are evenly mixed, and obtaining finished products after packaging, wherein the weight of each table or each capsule is 0.3 g.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a pharmaceutical composition for preventing and treating cardiovascular and cerebrovascular diseases. Background technique [0002] With the improvement of people's living standards, the pace of life is accelerating, the pressure of family and career is increasing, and the mood is becoming more and more unstable; at the same time, excessive drinking, intake of too much food fat, lack of necessary exercise, and living environment Pollution, the decrease of negative ion content in the air leads to insufficient intake of negative ions in the body. These factors directly slow down the body's metabolism, decrease blood flow rate, and increase blood viscosity, resulting in insufficient blood supply to the heart and brain. Long-term hypertension can thicken or harden the walls of cerebral arteries and narrow the lumen. When blood pressure rises sharply, cerebral blood vessels...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/488A61P9/10A61P3/10A61P3/06A61K35/62A61K31/557A61K31/202
CPCA61K36/488A61K31/202A61K31/557A61K35/62A61K36/258A61K36/31A61K2300/00
Inventor 曹永芬
Owner 曹永芬
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products